18-24-month HIV-free survival as measurement of the effectiveness of prevention of mother-to-child transmission in the context of lifelong antiretroviral therapy: Results of a community-based survey.

Authors

Appolinaire Tiam
Michelle M Gill
Rhoderick Machekano
Vincent Tukei
Majoalane Mokone
Shannon Viana
Mosilinyane Letsie, George Washington University
Mots'oane Tsietso, George Washington University
Irene Seipati, George Washington University
Cecilia Khachane, George Washington University
Marethabile Nei
Florence Mohai
Thorkild Tylleskär
Laura Guay, George Washington University

Document Type

Journal Article

Publication Date

10-1-2020

Journal

PLoS One

Volume

15

Issue

10

Inclusive Pages

e0237409

DOI

10.1371/journal.pone.0237409

Comments

eCollection 2020

APA Citation

Tiam, A., Gill, M., Machekano, R., Tukei, V., Mokone, M., Viana, S., Letsie, M., Tsietso, M., Seipati, I., Khachane, C., Nei, M., Mohai, F., Tylleskär, T., & Guay, L. (2020). 18-24-month HIV-free survival as measurement of the effectiveness of prevention of mother-to-child transmission in the context of lifelong antiretroviral therapy: Results of a community-based survey.. PLoS One, 15 (10). http://dx.doi.org/10.1371/journal.pone.0237409

Peer Reviewed

1

Open Access

1